Form 4: CareDx Director Peter Maag Sells 13,281 Shares Under 10b5-1 Trading Plan

Peter Maag, a director at CareDx, Inc., sold 13,281 shares of common stock on April 30, 2025, at a weighted average price of $17.2273 per share, according to a Form 4 filing with the SEC.

Summary

• On April 30, 2025, Peter Maag, a director of CareDx, Inc. (CDNA), sold 13,281 shares of the company's common stock.
• The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 21, 2024.
• The shares were sold at a weighted average price of $17.2273, with individual transaction prices ranging from $16.8500 to $17.6900.
• Following the transaction, Peter Maag directly owns 316,743 shares of CareDx, Inc.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to a stock sale by a company director under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment.

Industry Context

Sales by company insiders are a common occurrence and are often related to personal financial planning. The use of a 10b5-1 trading plan allows insiders to sell shares over a period of time without being accused of trading on non-public information.

Stakeholder Impact

• The sale of shares by a director could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates

Keywords

CareDx, Peter Maag, Form 4, SEC Filing, Stock Sale, Director, CDNA, Rule 10b5-1 Trading Plan